VANCOUVER, May 1 /CNW/ - Ondine Biopharma Corporation (“the Company”, TSX: OBP; AIM: OBP) today announced the appointment of Mr. Michael Richard Crane to its Board of Directors. Mr. Crane is an accomplished Senior Executive who is experienced in the Dental/Medical high-tech equipment and consumables industry.
